Novo Nordisk
NVO
#31
Rank
HK$2.410 T
Marketcap
HK$560.58
Share price
2.94%
Change (1 day)
-46.00%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total assets

Total assets on the balance sheet as of March 2025 : HK$556.38 Billion

According to Novo Nordisk's latest financial reports the company's total assets are HK$556.38 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novo Nordisk - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$504.57 B38.71%
2023-12-31HK$363.76 B34.01%
2022-12-31HK$271.45 B17.56%
2021-12-31HK$230.91 B24.34%
2020-12-31HK$185.70 B26.61%
2019-12-31HK$146.67 B10.37%
2018-12-31HK$132.89 B3.09%
2017-12-31HK$128.92 B20.38%
2016-12-31HK$107.09 B2.71%
2015-12-31HK$104.26 B6.8%
2014-12-31HK$97.62 B-3.32%
2013-12-31HK$100.98 B11.88%
2012-12-31HK$90.25 B3.1%
2011-12-31HK$87.54 B2.65%
2010-12-31HK$85.27 B4.3%
2009-12-31HK$81.76 B11.08%
2008-12-31HK$73.60 B0.93%
2007-12-31HK$72.93 B18.32%
2006-12-31HK$61.63 B19.84%
2005-12-31HK$51.43 B-3.55%
2004-12-31HK$53.32 B17.95%
2003-12-31HK$45.21 B20.65%
2002-12-31HK$37.47 B9.11%
2001-12-31HK$34.34 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
HK$1.631 T 193.14%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$700.83 B 25.96%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$724.65 B 30.24%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.119 T 101.17%๐Ÿ‡ซ๐Ÿ‡ท France